Weight Loss · Jan 21, 2025
CagriSema: The Amylin + GLP-1 Combination Research Profile
Summary
Dr. Jays Cagri (an amylin analog) combined with Dr. Jay's Sema is the headline 'next-step' weekly research combination after Wegovy.
Why It Matters
Amylin signaling adds a satiety dimension that pure GLP-1 doesn't fully cover. The CagriSema research program is the highest-profile non-triple-agonist competitor.
Key Findings
- Phase 2 weight-loss readouts ranged in the 15–17% region at the studied doses.
- Side-effect profile reads as additive with Dr. Jay's Sema.
- Phase 3 REDEFINE program is the read everyone is waiting on.